Inventor
BARTSEVICH VICTOR
US20 patents
Patents
20 patentsUS9889160B2Feb 13, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC65 citations98
US9889161B2Feb 13, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC27 citations97
US10093900B2Oct 9, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC15 citations92
US10093899B1Oct 9, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC8 citations92
US9993502B1Jun 12, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC16 citations92
US9993501B2Jun 12, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC11 citations92
US9969975B1May 15, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC13 citations92
US9950010B1Apr 24, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC14 citations92
US9950011B1Apr 24, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC14 citations92
US10799535B2Oct 13, 2020
Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC5 citations84
US10603363B2Mar 31, 2020
Treatment of retinitis pigmentosa using engineered meganucleases
PREC BIOSCIENCES INC3 citations73
US11680254B2Jun 20, 2023
Engineered meganucleases specific for recognition sequences in the PCSK9 gene
PREC BIOSCIENCES INC3 citations72
US11142750B2Oct 12, 2021
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
PREC BIOSCIENCES INC3 citations72
US12595469B2Apr 7, 2026
Treatment of retinitis pigmentosa using improved engineered meganucleases
PREC BIOSCIENCES INC0 citations62
US11788077B2Oct 17, 2023
Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
PREC BIOSCIENCES INC0 citations62
US11266693B2Mar 8, 2022
Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC0 citations62
US11268065B2Mar 8, 2022
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC0 citations62
US11278632B2Mar 22, 2022
Engineered nucleases useful for treatment of hemophilia A
PREC BIOSCIENCES INC0 citations61
US12595470B2Apr 7, 2026
Engineered nucleases that target human and canine factor VIII genes as a treatment for hemophilia A
PREC BIOSCIENCES INC0 citations57
US10758595B2Sep 1, 2020
Treatment of retinitis pigmentosa using engineered meganucleases
PREC BIOSCIENCES INC0 citations52